News and Media

Latest News Release
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health Applauds the FDA Anti-counterfeit Report
06/12/2006

DUBLIN, Ohio, June 12, 2006— Cardinal Health, Inc., the leading provider of products and services supporting the health-care industry, issued the following statement concerning release of the Food and Drug Administration’s (FDA) anti-counterfeit report and recommendation to implement provisions of the Prescription Drug Marketing Act (PDMA).

 

 

Cardinal Health applauds steps taken by the FDA to help ensure the safety and security of our nation’s pharmaceutical supply.  We believe that direct distribution of medicine is the best near-term step to further secure the supply chain, which is one of the reasons Cardinal Health initiated this approach for all pharmaceuticals in 2005.  In addition, we announced our support for enactment of the PDMA pedigree regulations in February, 2006 and recently launched the industry’s first end-to-end pilot program to test the use of radio frequency identification (RFID) under real-world conditions. 

 

The safety and security of our nation’s pharmaceutical supply is Cardinal Health’s top priority and a responsibility we take very seriously.  A safe and reliable drug supply is central to our customers’ business and critical to the health and well being of patients. 

 

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $75 billion, global company serving the health-care industry with a broad portfolio of products and services.  Through its diverse offering, Cardinal Health delivers integrated health-care solutions that help customers reduce their costs, improve efficiency and deliver better care to patients.  The company manufactures, packages and distributes pharmaceuticals and medical supplies, offers a range of clinical services and develops automation products that improve the management and delivery of supplies and medication for hospitals, physician offices and pharmacies.  Ranked No. 19 on the Fortune 500, Cardinal Health employs more than 55,000 people on six continents.  More information about the company may be found at www.cardinalhealth.com.

More Company News
05/07/2024

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5056 per share, out of the Company's capital surplus. The dividend...

05/02/2024

Revenue increased 9% to $54.9 billion GAAP1 operating earnings were $367 million; GAAP diluted EPS was $1.05 Non-GAAP operating earnings increased 10% to $666 million; non-GAAP diluted EPS...

04/22/2024

Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed. The company reaffirmed its...

04/02/2024

The Consumer Health Logistics Center will be located in Central Ohio and serve as a centralized hub for distribution of consumer health products COLUMBUS, Ohio, April 2, 2024 /PRNewswire/ --...

View all company news »